An overview on ELISA techniques for FMD

Virology Journal

Volumn 8, Issue , 2011, Pages

  Ma, Li Na ^a   Zhang, Jie ^a   Chen, Hao Tai ^a   Zhou, Jian Hua ^a   Ding, Yao Zhong ^a   Liu, Yong Sheng ^a  

^a National Foot and Mouth Disease Reference Laboratory   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS ANTIBODY; VIRUS VACCINE;

DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; VACCINATION; VIRUS CAPSID; VIRUS INACTIVATION; ANIMAL; CATTLE; CATTLE DISEASE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DNA FINGERPRINTING; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; STANDARD; SWINE; SWINE DISEASE; VESICULAR STOMATITIS; VIROLOGY;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CATTLE; CATTLE DISEASES; DIAGNOSIS, DIFFERENTIAL; DISEASE ERADICATION; DNA FINGERPRINTING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MICE; SENSITIVITY AND SPECIFICITY; SWINE; SWINE DISEASES; VESICULAR STOMATITIS; VIRAL VACCINES;

EID: 80052235169     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-419     Document Type: Review

References (117)

1. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family, aspects of virus protein synthesis, protein processing and structure. Belsham GJ, Prog Biophys Mol Biol 1993 60 241 260 10.1016/0079-6107(93)90016-D 8396787
2. Molecular basis of pathogenesis of FMDV. Mason PW, Grubman MJ, Baxt B, Virus Res 2003 91 9 32 10.1016/S0168-1702(02)00257-5 12527435 (Pubitemid 36078428)
3. Comparative genomics of foot and mouth disease virus. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL, J Virol 2005 79 6487 6504 10.1128/JVI.79.10.6487-6504.2005 15858032 (Pubitemid 40617252)
4. Evolution of foot-and-mouth disease virus. Domingo E, Escarmis C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Nunez JI, Sobrino F, Virus Res 2003 91 47 63 10.1016/S0168-1702(02)00259-9 12527437 (Pubitemid 36078430)
5. Subtyping of foot and mouth disease virus. Pereira HG, Dev Biol Stand 1977 35 167 174 (Pubitemid 9054138)
6. The World Reference Laboratory for Foot and Mouth Disease: a review of thirty-three years of activity (1958-1991). Ferris NP, Donaldson AI, Rev sci tech Off int epiz 1992 11 657 684
7. Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Roeder PL, Le Blanc Smith PM, Res Vet Sci 1987 43 225 232 2825310
8. Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular disease. Ferris NP, Dawson M, Vet Microbiol 1988 16 201 209 10.1016/0378-1135(88)90024-7 3376418
9. A rapid enzyme-linked immunosorbent assay for the detection of foot-and-mouth disease virus in epithelial tissues. Hamblin C, Armstrong RM, Hedger RS, Vet Microbiol 1984 9 435 443 10.1016/0378-1135(84)90064-6 6093338 (Pubitemid 14039113)
10. An enzyme-linked immunosorbent assay (ELISA) for the primary diagnosis of foot and-mouth disease. Have P, Lei JC, Schjerning-Thiesen K, Acta Vet Scand 1984 25 280 296 6095628
11. Detection of foot-and-mouth disease virus by competitive ELISA using a monoclonal antibody specific for the 12S protein subunit from six of the seven serotypes. Smitsaart EN, Saiz JC, Yedloutschnig RJ, Morgan DO, Vet Immunol Immunopathol 1990 26 251 265 10.1016/0165-2427(90)90095-A 1702246 (Pubitemid 20360258)
12. Use of pre-coated immunoplates and freeze-dried reagents for the diagnosis of foot-and-mouth disease and swine vesicular disease by enzyme-linked immunosorbent assay (ELISA). Ferris NP, Powell H, Donaldson AI, J Virol Methods 1988 19 197 206 10.1016/0166-0934(88)90014-6 2836457
13. Application of agar gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. Brown F, Crick L, J Immunol 1959 82 444 447 13641679
14. Antibody response to the noninfectious 7 Mu component of the virus of foot-and-mouth disease. Ceglowski WS, Virology 1965 25 328 330 10.1016/0042-6822(65)90212-6 14297221
15. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and-mouth disease and polio viruses. Meloen RH, Rowlands DJ, Brown F, J Gen Virol 1979 45 761 763 10.1099/0022-1317-45-3-761 94352 (Pubitemid 10184469)
16. Serological and immunological relationships between the 146S and 12S particles of foot-and-mouth disease virus. Cartwright B, Chapman WG, Brown F, J Gen Virol 1980 50 369 375 10.1099/0022-1317-50-2-369 6257825 (Pubitemid 11182594)
17. Application of a monoclonal antibody based competition ELISA to the measurement of anti-FMDV antibodies in animal sera. Brocchi E, De Simone F, Bugnetti M, Gamba D, Capucci L, Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease: 24-25 June, 1990; Lindholm, Denmark 1990 83 88 (Appendix 14)
18. A complex-trapping-blocking ELISA using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C, I. Method and characteristics. Van Maanen C, Vet Microbiol 1990 24 171 178 10.1016/0378-1135(90)90064-3 2173248 (Pubitemid 20280492)
19. Evaluation of a trapping ELISA for the differentiation of foot-and mouth disease virus strains using monoclonal antibodies. Samuel AR, Knowles NJ, Samuel GD, Crowther JR, Biologicals 1991 19 299 310 10.1016/S1045-1056(05)80019-3 1665700
20. Development of reverse transcription-PCR (oligonucleotide probing) enzyme linked immunosorbent assays for diagnosis and preliminary typing of foot-and-mouth disease: a new system using simple and aqueous phase hybridization. Alexandersen S, Forsyth MA, Reid SM, Belsham GJ, J Clin Microbiol 2000 38 4604 4613 11101603 (Pubitemid 32244556)
21. Development and comparison of genome detection assays for the diagnosis of foot-and-mouth disease suspected clinical samples. Mohapatra JK, Sanyal A, Hemadri D, Tosh C, Palani G, Rasool TJ, Bandyopadhyay SK, J Virol Methods 2006 137 14 20 10.1016/j.jviromet.2006.05.022 16814877 (Pubitemid 44209270)
22. Establishment of indirect ELISA diagnose based on the VP1 structural protein of foot-and-mouth disease virus (FMDV) in pigs. Wang GH, Du JZ, Cong GZ, Shao JJ, Lin T, Xue HW, Chang HY, Xie QG, Sheng Wu Gong Cheng Xue Bao 2007 23 961 6 18051883
23. Serotype-independent detection of foot-and-mouth disease virus. Muller JD, McEachern JA, Bossart KN, Hansson E, Yu M, Clavijo A, Hammond JM, Wang L, J Virol Methods 2008 151 146 153 10.1016/j.jviromet.2008.03.011 18440078
24. Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. Freiberg B, Höhlich B, Haas B, Saalmüller A, Pfaff E, Marquardt O, J Virol Methods 2001 92 199 205 10.1016/S0166-0934(00)00287-1 11226567 (Pubitemid 32171988)
25. Production and characterisation of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Yang M, Clavijo A, Suarez-Banmann R, Avalo R, Vet Immunol Immunopathol 2007 115 126 134 10.1016/j.vetimm.2006.10.002 17109972 (Pubitemid 44920264)
26. Characterization of foot-and-mouth disease vírus by monoclonal antibodies. Alonso A, Gomes MD, Ramalho AK, Allende R, Barahona H, Sondhal M, Osorio F, Viral Immunol 1993 6 219 228 10.1089/vim.1993.6.219 7507329
27. Characterization of Monoclonal Antibodies Against Foot and Mouth Disease Virus and Determination of Antigenic Variations in Field Strains. Gürhan SI, Gürhan B, Aynagöz G, nal N, nver G, TURK J VET ANIM SCI 1999 23 403 408 (Pubitemid 129634207)
28. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination. Hamblin C, Kitching RP, Donaldson AI, Crowther JR, Barnett IT, Epidemiol Infect 1987 99 733 44 10.1017/S0950268800066590 3428376 (Pubitemid 18034347)
29. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. Van Maanen C, Terpstra C, J Immunol Methods 1989 124 111 9 10.1016/0022-1759(89)90192-0 2553819 (Pubitemid 19276875)
30. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Kitching RP, Rendle R, Ferris NP, Vaccine 1988 6 403 408 10.1016/0264-410X(88)90139-9 2848376
31. Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988. Samuel AR, Ouldridge EJ, Arrowsmith AEM, Kitching RP, Knowles NJ, Vaccine 1990 8 390 396 10.1016/0264-410X(90)90100-Z 2168609 (Pubitemid 20264819)
32. Localization of infection-related epitopes on the non-structural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes. Sun T, Lu P, Wang X, J Virol Methods 2004 119 79 86 10.1016/j.jviromet.2004.02.016 15158588 (Pubitemid 38670398)
33. Immunochemistry of sperm whale myoglobin. 8. Specific interaction of peptides obtained by cleavage at proline peptide bonds. Atassi MZ, Singhal RP, Biochemistry 1970 9 20 3854 61 10.1021/bi00822a002 5501645
34. Strategies for epitope analysis using peptide synthesis. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG, J Immunol Methods 1987 102 259 10.1016/0022-1759(87)90085-8 2443575 (Pubitemid 17139413)
35. Multipin peptide libraries for antibody and receptor epitope screening and characterization. Tribbick G, J Immunol Methods 2002 267 27 35 (Review) 10.1016/S0022-1759(02)00138-2 12135798 (Pubitemid 34804810)
36. A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. McCullough KC, Crowther JR, Butcher RN, J Virol Methods 1985 11 329 338 10.1016/0166-0934(85)90026-6 2414308 (Pubitemid 16237730)
37. Epitope Mapping of Foot-and-Mouth Disease Virus with Neutralizing Monoclonal Antibodies. Bolwell C, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ, J Gen Virol 1989 70 59 68 10.1099/0022-1317-70-1-59 2471783
38. A 10-aminoacid linear sequence of VP1 of foot and mouth disease virus (FMDV) containing B and T-cell epitopes induces protection in mice. Zamorano P, Wigdorovitz A, Perez-Filgueira DM, Carrillo C, Escribano JA, Sadir AM, Borca MV, Virology 1995 212 614 621 10.1006/viro.1995.1519 7571431
39. Detection and Characterization of Functional T-Cell Epitopes on the Structural Proteins VP2, VP3, and VP4 of Foot and Mouth Disease Virus O1 Campos. Filgueira MP, Wigdorovitz A, Romera A, Zamorano P, Borca MV, Sadir AM, Virology 2000 271 234 239 10.1006/viro.2000.0281 10860876 (Pubitemid 30461300)
40. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E, Virology 1995 206 298 306 10.1016/S0042-6822(95)80045-X 7831785
41. Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia 1. Zhang ZW, Zhang YG, Wang YL, Pan L, Fang YZ, Jiang ST, Lü JL, Zhou P, Vet Microbiol 2010 140 25 33 10.1016/j.vetmic.2009.07.011 19699594
42. Development and evaluation of an indirect enzyme-linked immunosorbent assay for detection of foot-and-mouth disease virus nonstructural protein antibody using a chemically synthesized 2B peptide as antigen. Inoue T, Parida S, Paton DJ, Linchongsubongkoch W, Mackay D, Oh Y, Aunpomma D, Gubbins S, Saeki T, J Vet Diagn Invest 2006 18 545 552 10.1177/104063870601800604 17121081 (Pubitemid 44770990)
43. Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle. Höhlich BJ, Wiesmüler KH, Schlapp T, Haas B, Pfaff E, Saalmüller A, J Virol 2003 77 8633 9 10.1128/JVI.77.16.8633-8639.2003 12885881 (Pubitemid 36936073)
44. Identification of T-cell epitopes in non-structural proteins of foot-and mouth disease virus. Blanco E, Garcia-Briones M, Sanz-Parra A, Gomes P, De Oliveira E, Valero ML, Andreu D, Ley V, Sobrino F, J Virol 2001 75 3164 3174 10.1128/JVI.75.7.3164-3174.2001 11238843 (Pubitemid 32225880)
45. The use of monoclonal antibodies in the molecular typing of animal viruses. Crowther JR, Rev Sci Tech Off Int Des Epiz 1993 12 369 383
46. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Robertson BH, Morgan DO, Moore DM, Virus Res 1984 1 489 500 10.1016/0168-1702(84)90006-6 6085200 (Pubitemid 14047973)
47. Epitopes on foot-and-mouth disease virus particles. I. Topology. McCullough KC, Crowther JR, Carpenter WC, Broochi E, Capucci L, de Simone F, Xie Q, McCahon D, Virology 1987 157 516 525 10.1016/0042-6822(87)90294-7 2435060 (Pubitemid 17047707)
48. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Mateu MG, Da Silva JL, Rocha E, De Brum DL, Alonso A, Enjuanes L, Domingo E, Barahona H, Virology 1988 167 113 24 10.1016/0042-6822(88)90060-8 2460992
49. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus. Moore DM, Vakharia VN, Morgan DO, Virus Res 1989 14 281 295 10.1016/0168-1702(89)90022-1 2483013 (Pubitemid 20014457)
50. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C, Venkataramanan R, Pattnaik B, Hemadri D, Sanyal A, Acta Virologica 1999 43 219 225 10749367 (Pubitemid 29430387)
51. Development of foot-and-mouth disease virus strain characterization. Kitching RP, Knowles NJ, Samuel AR, Donaldson AI, Trop Anim Health Prod 1989 21 153 166 10.1007/BF02250825 2552629
52. Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Thomas AAM, Woortmeijer RJ, Barteling SJ, Meloen RH, Arch Virol 1988 99 237 242 10.1007/BF01311072 2453185
53. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN, Parkhouse RME, J Gen Virol 1998 79 1687 1697 9680132 (Pubitemid 28330673)
54. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. Aggarwal N, Barnett PV, J Gen Virol 2002 83 775 782 11907326 (Pubitemid 34284861)
55. FMD vaccines. Doel TR, Virus Res 2003 91 81 89 10.1016/S0168-1702(02) 00261-7 12527439 (Pubitemid 36078432)
56. A third antigenic component associated with foot-and mouth disease infection. Cowan KM, Graves JH, Virology 1966 30 528 540 10.1016/0042-6822(66) 90128-0 4958622
57. Poliovirus-specific primer-dependent RNA polymerase able to copy poly(A). Flanegan JB, Baltimore D, Proc Natl Acad Sci USA 1977 74 3677 3680 10.1073/pnas.74.9.3677 198796 (Pubitemid 8189945)
58. Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Clavijo A, Wright P, Kitching P, Vet J 2004 167 9 22 10.1016/S1090-0233(03)00087-X 14623146 (Pubitemid 37554937)
59. Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LBPE) with a bioengineered 3D protein. O'Donnel VK, Boyle DB, Sproat K, Fondevila NA, Forman A, Schudel A, Smitsaart EN, J Vet Diagn Invest 1996 8 143 150 10.1177/104063879600800201 8744733 (Pubitemid 126672320)
60. Antibodies to foot-and-mouth disease virus infection associated (VIA) antigen: use of a bioengineered VIA protein as antigen in an ELISA. Villinger F, Mueller HK, Bruckner L, Ackermann M, Kih U, Vet Microbiol 1989 20 235 246 10.1016/0378-1135(89)90047-3 2549685 (Pubitemid 19190585)
61. A new enzyme linked immunosorbent assay (ELISA) for the detection of antibodies against FMD virus. 1. Development and method of ELISA. Hamblin C, Barnett ITR, Hedger RS, J Immunol Methods 1986 93 115 121 10.1016/0022-1759(86) 90441-2 3021854 (Pubitemid 16005486)
62. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Paul AV, van Boom JH, Filippov D, Wimmer E, Nature 1998 393 280 284 10.1038/30529 9607767 (Pubitemid 28261729)
63. Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. Pacheco JM, Henry TM, O'Donnell VK, Gregory JB, Mason PW, J Virol 2003 77 13017 13027 10.1128/JVI.77.24.13017-13027.2003 14645558 (Pubitemid 37494297)
64. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus. Oem JK, Chang BS, Joo HD, Yang MY, Kim GJ, Park JY, Ko YJ, Kim YJ, Park JH, Joo YS, J Virol Methods 2007 142 174 181 10.1016/j.jviromet.2007.01.025 17336400 (Pubitemid 46590418)
65. Specificity of enzyme substrate interactions in foot-and-mouth disease virus polyprotein processing. Ryan MD, Belsham GJ, King AMQ, J Virol 1989 174 10 15
66. RNA signals in entero-and rhinovirus genome replication. Xiang W, Andino AV, Wimmer E, Semin Virol 1997 8 256 273 10.1006/smvy.1997.0128 (Pubitemid 28135184)
67. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. O'Donnell VK, Pacheco JM, Henry TM, Mason PW, Virology 2001 287 151 162 10.1006/viro.2001.1035 11504550 (Pubitemid 32778247)
68. Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Rodriguez A, Dopazo J, Saiz JC, Sobrino F, Arch Virol 1994 136 123 131 10.1007/BF01538822 8002780 (Pubitemid 2090279)
69. The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Diego DM, Brocchi E, Mackay D, Simone DF, Arch Virol 1997 142 2021 2033 10.1007/s007050050219 9413510 (Pubitemid 27510318)
70. Diagnostic potential of mab-based ELISAs for antibodies to non-structural proteins of foot-and-mouth disease virus to differentiate infection from vaccination. Brocchi E, De Diego MI, Berlinzani A, Gamba D, De Simone F, Vet Q 1998 20 Suppl 2 20 S24 9652058
71. Serological evidence of FMD subclinical infection in sheep population during the 1999 epidemic in Morocco. Blanco E, Romero LJ, Harrach ME, Sanchez-Vizcaino JM, Vet Microbiol 2002 85 13 21 10.1016/S0378-1135(01)00473-4 11792487 (Pubitemid 34127648)
72. Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins. Mezencio JM, Babcock GD, Meyer RF, Lubroth J, Salt JS, Newman JF, Brown F, Vet Q 1998 20 Suppl 2 11 3 9652055
73. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-stuctural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Sorensen KJ, Madsen KG, Madsen ES, Salt JS, Nqindi J, Mackay DKJ, Arch Virol 1998 143 1461 1476 10.1007/s007050050390 9739326 (Pubitemid 28417779)
74. Development of a foot-and-mouth disease NSP ELISA and its comparison with differential diagnostic methods. Kweon YH, Ko YJ, Kim WII, Lee SY, Naha JJ, Lee KN, Sohna HJ, Choi KS, Hyuna BH, Kanga SW, Joo YS, Lubroth J, Vaccine 2003 21 1409 1414 10.1016/S0264-410X(02)00684-9 12615437 (Pubitemid 36263182)
75. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Sørensen KJ, De Stricker K, Dyrting KC, Grazioli S, Haas B, Arch Virol 2005 150 805 814 10.1007/s00705-004- 0455-z 15645377 (Pubitemid 40560827)
76. Development and use of a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. Clavijo A, Zhou EM, Hole K, Galic B, Kitching P, J Virol Methods 2004 120 217 227 10.1016/j.jviromet.2004.05.007 15288965 (Pubitemid 39037411)
77. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli S, de Simone F, Yadin H, Haas B, Bulut N, Malirat V, Neitzert E, Goris N, Parida S, Sorensen K, de Clercq K, Vaccine 2006 24 6966 79 10.1016/j.vaccine.2006.04.050 16753241 (Pubitemid 46131395)
78. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Lu Z, Cao Y, Guo J, Qi S, Li D, Zhang Q, Ma J, Chang H, Liu Z, Liu X, Xie Q, Vet Microbiol 2007 125 157 169 10.1016/j.vetmic.2007.05.017 17601688 (Pubitemid 47454676)
79. Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 non-strucutural protein. Silberstein E, Kaplan G, Taboga O, Duffy S, Palma E, Arch Virol 1997 142 795 805 10.1007/s007050050119 9170505 (Pubitemid 27185683)
80. Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. Meyer RF, Babcock GD, Newman JF, Burrage TG, Toohey K, Lubroth J, Brown F, J Virol Methods 1997 65 33 43 10.1016/S0166-0934(96)02165-9 9128860 (Pubitemid 27146277)
81. Development of synthetic peptide ELISA based on nonstructural protein 2C of foot and mouth disease virus. Oem JK, Kye SJ, Lee KN, Park JH, Kim YJ, Song HJ, Yeh M, J Vet Sci 2005 6 317 25 16293996 (Pubitemid 43127010)
82. Differentiation of convalescent animals from those vaccinated against foot-and-mount disease by a peptide ELISA. Shen F, Chen PD, Walfield AM, Ye J, House J, Brown F, Wang CY, Vaccine 1999 17 3039 49 10.1016/S0264-410X(99)00148-6 10462239 (Pubitemid 29366984)
83. Production and application of recombinant antibodies to foot-and mouth disease virus non-structural protein 3ABC. Foord AJ, Muller JD, Yu M, Wang LF, Heine HG, J Immunol Methods 2007 321 142 151 10.1016/j.jim.2007.01.014 17328909 (Pubitemid 46441205)
84. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies. Hema M, Nagendrakumar SB, Yamini R, Chandran D, Rajendra L, Thiagarajan D, Parida S, Paton DJ, Srinivasan VA, Vaccine 2007 25 4784 4794 10.1016/j.vaccine.2007.04.023 17499404 (Pubitemid 46839076)
85. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Forss S, Strebel K, Beck E, Schaller H, Nucleic Acids Res 1984 12 6587 6601 10.1093/nar/12.16.6587 6089122
86. Nucleotide and amino acid sequence coding for polypeptides of foot-and mouth disease virus type A12. Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T, Dowbenko DJ, Yansura DG, Small B, Kleid DG, J Virol 1985 54 651 660 2987518 (Pubitemid 15014696)
87. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1. Ko YJ, Jeoung HY, Lee HS, Chang BS, Hong SM, Heo EJ, Lee KN, Joo HD, Kima SM, Park JH, Kweon CH, J Virol Methods 2009 159 112 118 10.1016/j.jviromet.2009.03.011 19442854
88. Further developments in the quantification of small RNA viruses by UV photometry of sucrose density gradients. Doel TR, Fletton B, Staple RF, Dev Biol Stand 1982 50 209 219
89. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies. Van Maanen C, Terpstra C, Biologicals 1990 18 315 319 10.1016/1045-1056(90)90036-Y 2178351
90. Quantification of whole virus particles (146S) of foot-and-mouth disease virus in the presence of virus subunits (12S), using monoclonal antibodies in a sandwich ELISA. Crowther JR, Reckziegel PO, Prado JA, Vaccine 1995 13 1064 75 10.1016/0264-410X(95)00051-2 7491813
91. Application of monoclonal antibodies to quality control of foot-and-mouth disease. Alonso A, Darsie GC, Teixeira AC, Reis JL, Mesquita JA, Vaccine 1994 12 682 686 10.1016/0264-410X(94)90216-X 8091844 (Pubitemid 24182366)
92. Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture. Yang M, Holland H, Clavijo A, Vaccine 2008 26 3377 3382 10.1016/j.vaccine.2008.04.062 18513841
93. Development of an in process control filtration-assisted chemiluminometric immunoassay to quantify foot and mouth disease virus (FMDV) non-capsid proteins in vaccine-antigen batches. Capozzo AV, Martínez MR, Schielen WJG, Vaccine 2010 28 6647 6652 10.1016/j.vaccine.2010.05.049 20685600
94. Analysis of the immune response to FMDV structural and nonstructural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Robiolo B, Seki C, Fondevilla N, Grigera P, Scodeller E, Periolo O, La Torre J, Mattion N, Vaccine 2006 13 997 1008 (Pubitemid 43185318)
95. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. Chenard G, Miedema K, Moonen P, Schrijver RS, Dekker A, J Virol Methods 2003 107 89 98 10.1016/S0166-0934(02)00196-9 12445942 (Pubitemid 35373911)
96. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. Mackay DKJ, Bulut AN, Rendle T, Davidson F, Ferris NP, J Virol Methods 2001 97 33 48 10.1016/S0166-0934(01)00333-0 11483215 (Pubitemid 32718739)
97. Validation of a foot-and-mouth disease antibody screening solid phase competition ELISA (SPCE). Paiba GA, Anderson J, Paton DJ, Soldan AW, Alexandersen S, Corteyn M, Wilsden G, Hamblin P, Mackay DK, Donaldson AI, J Virol Methods 2004 115 145 158 10.1016/j.jviromet.2003.09.016 14667530 (Pubitemid 37506029)
98. Improvement of serodiagnostic strategy for foot and mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot. Bergmann IE, Malirat V, Neitzert E, Panizutti N, Sanchez C, Falczuk A, Arch Virol 2000 145 473 489 10.1007/s007050050040 10795516 (Pubitemid 30172070)
99. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, nonstructural proteins in ELISA. Mackay DKJ, Forsyth MA, Davies PR, Berlinzani A, Belsham GJ, Flint M, Ryan MD, Vaccine 1998 16 446 459 10.1016/S0264-410X(97)00227-2 9491499 (Pubitemid 28044162)
100. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. McCullough KC, Butcher R, Arch Virol 1982 74 1 9 10.1007/BF01320777 6186225 (Pubitemid 13219692)
101. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1. Butchaiah G, Rao BU, Acta Virol 1989 33 121 130 2569807 (Pubitemid 19099957)
102. Antigenic relationships of foot-and-mouth disease virus serotype Asia-1 isolates demonstrated by monoclonal antibodies. Butchaiah G, Card JL, Morgan DO, Vet Immunol Immunopathol 1992 30 275 292 10.1016/0165-2427(92)90144-F 1375792
103. Characterization of monoclonal antibodies against a type SAT2 foot-and-mouth disease virus. Crowther JR, Rowe CA, Butcher R, Epidemiol Infect 1993 111 391 406 10.1017/S0950268800057083 7691630 (Pubitemid 23297357)
104. Mapping of neutralizing sites on FMD virus type Asia-1 and relationships with sites described in other serotypes. Grazioli S, Fallacara F, Brocchi E, Report of the Session of the Research Group of the Standing Committee of the European Commisssion of Foot and Mouth Disease: 2003 2003 277 287
105. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications. Yang M, Clavijo A, Li M, Hole K, Holland H, Wang H, Deng MY, J Immunol Methods 2007 321 174 181 10.1016/j.jim.2007.01.016 17320098 (Pubitemid 46441207)
106. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains. Rana SK, Bagchi T, Vet Immunol Immunopathol 2008 122 241 249 10.1016/j.vetimm.2008.01.001 18291535
107. Preparation and characterization of neutralizing monoclonal antibodies against FMDV serotype O with synthetic peptide antigen. Ma L, Liu Y, Ding Y, Chen H, Zhou J, Liu W, Wang M, Zhang J, Hybridoma 2010 29 409 412 10.1089/hyb.2010.0031 21050041
108. Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. Grubman MJ, Morgan DO, Kendall J, Baxt B, J Virol 1985 56 120 126 2411948 (Pubitemid 16256863)
109. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Rweyemamu MM, Terry G, Pay TWF, Arch Virol 1979 59 69 79 10.1007/BF01317896 218538 (Pubitemid 9100534)
110. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. Collen T, DiMarchi R, Doel T, J Immunol 1991 146 749 755 1702816
111. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. Collen T, Doel TR, J Gen Virol 1990 71 309 315 10.1099/0022-1317- 71-2-309 1689767 (Pubitemid 20059127)
112. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: Identification of T helper epitopes in VP1. Rodriguez A, Saiz JC, Novella IS, Andreu D, Sobrino F, Virology 1994 205 24 33 10.1006/viro.1994.1616 7526534
113. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. Saiz JC, Rodriguez A, Gonzalez M, Alonso F, Sobrino F, J Gen Virol 1992 73 2601 2607 10.1099/0022-1317-73-10-2601 1328475
114. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. Sáiz JC, Cairá J, Medina M, Zuidema D, Abrams C, Belsham GJ, Domingo E, Vlak JM, J Virol 1994 68 4557 4564 7515974 (Pubitemid 24183052)
115. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. Lewis SA, Morgan DO, Grubman MJ, J Virol 1992 65 6572 6580
116. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. Roosien J, Belsham GJ, Ryan MD, King AMQ, Vlak JM, J Gen Virol 1990 71 1703 1711 10.1099/0022-1317-71-8-1703 2167924 (Pubitemid 20248436)
117. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculoviru expression system and its utilization as a subunit vaccine. Li Z, Yi Y, Yin X, Zhang Z, Liu J, PloS One 2008 3 5 2273 10.1371/journal.pone. 0002273 18509464